Lightnews — Scholar-powered news

Elliot Tapper

@ebtapper.bsky.social

2.5K followers 440 following 500 posts

Hepatologist. #LiverSky / LiverLand. #MedSky. #cirrhosis Academic Chief of Hepatology at University of Michigan. Editor, Hepatology Communications. Kid Chauffeur

Posts Media Videos Starter Packs

Pinned

Elliot Tapper @ebtapper.bsky.social · Nov 15

We are on our second starter pack for GI / Hepatology
Part 1: go.bsky.app/8Pho2tp
Part 2: go.bsky.app/VGyLKjR

#medsky #GIsky #LiverSky

23 32 99

Elliot Tapper @ebtapper.bsky.social · Aug 30

1 in 5 Greek puppies with chronic kidney disease have advanced liver disease and it is the liver disease that is most linked to poor quality of life

2 5

Reposted by Elliot Tapper

Rob Brierley @robbrierley.bsky.social · Aug 28

New at The Lancet Public Health - Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies

www.thelancet.com/journals/lan...

#alcohol #LiverSky #MedSky

Targeting alcohol use in high-risk population groups: a US microsimulation study of beverage-specific pricing policies

Disproportionate increases in retail prices for the cheapest beverages, beer and spirits, might lead to a greater decline in consumption among high-risk groups. Pricing policies could thus be used as ...

www.thelancet.com

3 1

Reposted by Elliot Tapper

Lindsey Kennedy @livernotfighter.bsky.social · Aug 18

Dear #LiverSky #HepatoSky researchers:

PSC Partners grant cycle is now open! The deadline for your LOI is December 1, 2025

Need help crafting your grant? I offer editing services to help strengthen your proposal. Let's work together to make your work stand out!

pscpartners.org/research/res...

PSC Grant Application | Liver Research Grants | PSC Partners Seeking a Cure

Are you researching PSC? Do you need your medical research funded? At PSC Partners, we award grants to researchers answering important questions related to PSC. Apply.

pscpartners.org

Reposted by Elliot Tapper

Pierre Gholam MD @livermd.bsky.social · Aug 18

More #efruxifermin data this time in #MASH F2/F3 fibrosis @ 96 weeks

✅ Efficacy w/ dose dependent response (sort of) and NITs consistent
↔️ not crazy about mITT though it is mentioned no paired bx= non responders
⬇️ dose dependent reduction in bone mineral density

#liversky

BaladoCritique : club de lecture médical @baladocritique.bsky.social · Aug 16

"Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial.
Publié ce jour dans @thelancet.com
www.thelancet.com/journals/lan...

Safety and efficacy of once-weekly efruxifermin versus placebo in metabolic dysfunction-associated steatohepatitis (HARMONY): 96-week results from a multicentre, randomised, double-blind, placebo-cont...

Efruxifermin resulted in greater improvements in fibrosis than placebo after 96 weeks, warranting further investigation in phase 3 trials.

www.thelancet.com

1 3

Reposted by Elliot Tapper

AASLD @aasldnews.bsky.social · Aug 19

New hope for #liverhealth: FDA recently approved Wegovy as the 1st #GLP1 therapy for adults with serious #liverdisease. Research presented at TLM ‘24 demonstrated the groundbreaking treatment potential. Learn more: https://bit.ly/45phv4R

1 3 2

Elliot Tapper @ebtapper.bsky.social · Aug 20

journals.lww.com/hepcomm/full...

Endohepatology: Current perspectives and future directions : Hepatology Communications

field known as endoscopic hepatology or “endohepatology.” This domain integrates endoscopic diagnostic and therapeutic techniques, particularly those which are endoscopic ultrasound–based, into hepato...

journals.lww.com

1 3

Elliot Tapper @ebtapper.bsky.social · Aug 6

When did I start rounding?

4 10

Reposted by Elliot Tapper

thecurbsiders.bsky.social @thecurbsiders.bsky.social · Aug 4

🥾A reboot with endless pearls!

#452 NAFLD/MASLD! Expand your NAFLD/MASLD knowledge!

Expert guest @ebtapper.bsky.social shares his framework for approaching NAFLD/MASLD and the treatment tools he recommends including lifestyle modifications and medications.
www.thecurbsiders.com

1 5

Reposted by Elliot Tapper

josh farkas 💊 @pulmcrit.bsky.social · Jul 31

my take on procal:

1. zero role in ED, shouldn't be used to start ABX

2. CAN be super helpful in first 24 hr after ICU admit to help disprove sepsis in complex cases (eg aspiration pneumonitis or atelectasis masquerading as PNA). helps stop ABX & redirect.

3. not helpful in limiting ABX duration

REBEL EM @rebel-em.bsky.social · Jul 30

📉 Does trending biomarkers help stop antibiotics sooner safely in sepsis?

👀 More here: https://wp.me/pdrP8b-5mL

#FOAMed #EMIMCC #MedSky

2 1 14

Reposted by Elliot Tapper

thecurbsiders.bsky.social @thecurbsiders.bsky.social · Jul 16

🚨 High Yield Infographic Alert!

Elevated PTT? Think bleeding history.

🟢 Non-bleeders: APS, contact factor deficiencies, heparin.
🔴 Bleeders: Hemophilias, vWD, factor VIII inhibitors.

Not all prolonged PTTs mean bleeding risk.

#MedEd #Hematology #FOAMed #ElevatedPTT #TheCurbsiders

1 1 3

Reposted by Elliot Tapper

GarciaPagan @juanc60.bsky.social · Jul 20

Another piece of evidence about the role of anticoagulants in cirrhosis. Results of a multicenter effort. The cirroxaban study. @hospitalclinic.bsky.social @idibaps.bsky.social @jhepatology.bsky.social

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

ScienceDirect.com | Science, health and medical journals, full text articles and books.

kwnsfk27.r.eu-west-1.awstrack.me

2 4

Reposted by Elliot Tapper

Pierre Gholam MD @livermd.bsky.social · Jul 17

Jaume Bosch

No one, and I mean no one, made more seminal contributions to the measurement, interpretation & clinical applications of HVPG, the prognostic impact of CSPH and its rx.

Truly in the pantheon of all time greatest hepatologists and a kind, generous person on top.

RIP

#liversky

2 6